A business in context

OTLK research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-23 · 8022 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 8-K · Current report

    Report date 2026-09-25 · 0001104659-26-112356 · Items 3.01

  2. 8-K · Current report

    Report date 2026-09-16 · 0001104659-26-108952 · Items 8.01

  3. 4 · Ownership change

    Report date 2026-09-01 · 0002074701-26-000005

  4. 8-K · Current report

    Report date 2026-08-23 · 0001104659-26-102446 · Items 5.02,9.01

  5. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001104659-26-098415

  6. 4 · Ownership change

    Report date 2026-08-14 · 0001649989-26-000009

  7. 4 · Ownership change

    Report date 2026-08-14 · 0001104659-26-097406

  8. 8-K · Current report

    Report date 2026-08-12 · 0001104659-26-096510 · Items 8.01,9.01

  9. 8-K · Current report

    Report date 2026-08-14 · 0001104659-26-096478 · Items 2.02,9.01

  10. 4 · Ownership change

    Report date 2026-08-12 · 0000899140-26-000894

  11. 8-K · Current report

    Report date 2026-08-12 · 0001104659-26-094848 · Items 2.02,8.01,9.01

  12. 4 · Ownership change

    Report date 2026-07-29 · 0001649989-26-000008

  13. 8-K · Current report

    Report date 2026-07-24 · 0001104659-26-086685 · Items 8.01,9.01

  14. 8-K · Current report

    Report date 2026-07-21 · 0001104659-26-086406 · Items 5.02

  15. 4 · Ownership change

    Report date 2026-07-21 · 0001649989-26-000007

  16. 4 · Ownership change

    Report date 2026-07-21 · 0001649989-26-000006

  17. 8-K · Current report

    Report date 2026-07-16 · 0001104659-26-084242 · Items 5.03,5.07,9.01

  18. 8-K · Current report

    Report date 2026-06-26 · 0001104659-26-078337 · Items 3.01

  19. 8-K · Current report

    Report date 2026-06-16 · 0001104659-26-074346 · Items 8.01,9.01

  20. 4 · Ownership change

    Report date 2026-06-02 · 0001649989-26-000005

  21. DEF 14A · Proxy statement

    Report date 2026-07-16 · 0001140361-26-023583

  22. 8-K · Current report

    Report date 2026-06-01 · 0001104659-26-068659 · Items 8.01,9.01

  23. 8-K · Current report

    Report date 2026-05-29 · 0001104659-26-068306 · Items 8.01,9.01

  24. 8-K · Current report

    Report date 2026-05-28 · 0001104659-26-067614 · Items 8.01,9.01

  25. 8-K · Current report

    Report date 2026-05-26 · 0001104659-26-065992 · Items 8.01,9.01

  26. 8-K · Current report

    Report date 2026-05-15 · 0001104659-26-062865 · Items 2.02,9.01

  27. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001104659-26-062632

  28. 8-K · Current report

    Report date 2026-05-12 · 0001104659-26-060305 · Items 1.01,1.02,2.02,9.01

  29. 8-K · Current report

    Report date 2026-04-22 · 0001104659-26-047741 · Items 3.02,8.01,9.01

  30. 8-K · Current report

    Report date 2026-04-21 · 0001104659-26-046014 · Items 8.01,9.01

  31. 8-K · Current report

    Report date 2026-04-07 · 0001104659-26-040387 · Items 8.01,9.01

  32. 8-K · Current report

    Report date 2026-03-23 · 0001104659-26-034601 · Items 8.01,9.01

  33. 8-K · Current report

    Report date 2026-03-13 · 0001104659-26-028103 · Items 1.01,2.03,8.01,9.01

  34. 8-K · Current report

    Report date 2026-03-06 · 0001104659-26-026465 · Items 5.02,9.01

  35. 8-K · Current report

    Report date 2026-03-10 · 0001104659-26-025893 · Items 5.07,9.01

  36. 8-K · Current report

    Report date 2026-03-05 · 0001104659-26-024189 · Items 8.01,9.01

  37. 8-K · Current report

    Report date 2026-02-18 · 0001104659-26-017118 · Items 3.01

  38. 10-Q · Quarterly report

    Report date 2025-12-31 · 0001104659-26-016554

  39. 8-K · Current report

    Report date 2026-02-17 · 0001104659-26-015887 · Items 2.02,9.01

  40. 8-K · Current report

    Report date 2026-02-11 · 0001104659-26-013470 · Items 8.01,9.01

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-23 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 7 transaction rows7PSale: 0 transaction rows0SGrant / award: 3 transaction rows3AExercise / conversion: 0 transaction rows0MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

10 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-09-01
2026-09-02
Lundquist Kevin MichaelA · Grant / award
Acquired
Employee Stock Option (Right to Buy)
Derivative security
500000.00.0
2026-08-14
2026-08-14
KENYON LAWRENCE AP · Purchase
Acquired
Common Stock101010.0n/a
2026-08-14
2026-08-14
KENYON LAWRENCE AP · Purchase
Acquired
Warrants (right to buy)
Derivative security
101010.0n/a
2026-08-14
2026-08-14
Jahr Robert CharlesP · Purchase
Acquired
Common Stock151515.0n/a
2026-08-14
2026-08-14
Jahr Robert CharlesP · Purchase
Acquired
Warrants (right to buy)
Derivative security
151515.0n/a
2026-08-12
2026-08-14
GMS Ventures & Investments; Sukhtian Ghiath M.P · Purchase
Acquired
Common Stock2525252.00.99
2026-08-12
2026-08-14
GMS Ventures & Investments; Sukhtian Ghiath M.P · Purchase
Acquired
Warrants (right to buy)
Derivative security
2525252.00.0
2026-07-29
2026-07-29
Sukhtian Faisal GhiathP · Purchase
Acquired
Common Stock95398.01.05
2026-07-21
2026-07-23
KENYON LAWRENCE AA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
210078.00.0
2026-07-21
2026-07-23
Jahr Robert CharlesA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
100000.00.0

Identity & relationships

Wikidata structured data · retrieved 2026-10-23 · 1658 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001649989Outlook Therapeutics, Inc.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-10-23 · 1197 checked identities; 0 unavailable records

Search names and former names
  • Oncobiologics, Inc. · former SEC name · 2015-08-10 to 2018-11-13

Revenue in constant purchasing power

USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2025-09-30$1.41M$1.49M

Bureau of Labor Statistics · retrieved 2026-10-23 · 9 selected series; gaps remain missing

Explore the CPI history ↗